Loading...
Home2021-11-02T14:58:33+01:00

Parkinson’s Disease

Parkinson´s disease is a progressive neurodegenerative disorder.

READ MORE

The unique features of Infudopa™

READ MORE

Our products in development

READ MORE

“I have an ethical responsibility to contribute to Infudopa™ becoming available to patients suffering from Parkinson’s disease”

– Arvid Carlsson (1923-2018) who received the Nobel prize in 2000 for the discoveries that paved the way for the introduction of levodopa as treatment for Parkinson´s disease.

Dizlin Pharmaceuticals receives patent approval in the USA

Gothenburg, Sweden, April 25th, 2023 – Dizlin Pharmaceuticals AB, a research-based pharmaceutical development company with focus on diseases of the central nervous system (CNS), today announces a patent approval in the USA Dizlin Pharmaceuticals has [...]

CEO Letter, December 2022

Dizlin has during the autumn continued to work on prioritized projects according to the updated project plan. Progress has been made with pharmaceutical development, pump development and the regulatory application process.   The extensive work with [...]

Read all news

Dizlin Pharmaceuticals AB
c/o Sahlgrenska Science Park
Medicinaregatan 8A
SE-413 90 Gothenburg
Sweden
Website contact: bjorn.velin@dizlin.se

The information on this website is of general information nature and is not intended to replace personal medical advice from doctors and other healthcare professionals. Dizlin Pharmaceutical’s products are investigational drugs and are not approved for commercial use.

Dizlin Privacy Policy.
Dizlin Cookie Policy.

Dizlin Pharmaceuticals uses cookies in order to optimize your experience and use of our website as well as to be able to analyze the users’ usage of the website. Choose yourself if you would like to accept the cookies. Before you make your choice we encourage you to read our cookie policy. Do you accept our cookie policy? Settings Ok

Tracking Cookies

Third Party Embeds

Go to Top